BIOMAT Database Logo BIOMAT Database Logo

Mutation of potential N-linked glycosylation sites in the Alzheimer's disease amyloid precursor protein (APP). 1996

M Yazaki, and K Tagawa, and K Maruyama, and H Sorimachi, and T Tsuchiya, and S Ishiura, and K Suzuki
Institute of Molecular and Cellular Biosciences, University of Tokyo, Japan.

In order to study the mechanism of intracellular sorting and processing of the Alzheimer's disease amyloid precursor protein (APP), we deleted two potential N-linked glycosylation sites of APP by site-directed mutagenesis. Substitution of alanines for the critical asparagine residues Asn467 and Asn496 was performed. Wild-type and mutant APPs were expressed in COS-1 cells by cDNA transfection and the expressed of the protein and secretion of N-terminal large fragment was observed. The initial secretion of the mutant APP appeared to be slow compared with wild-type. In addition, we found that a distinct APP fragment, the cytosolic form, is transiently increased in the cytosol fraction of COS-1 cells. These results suggest that aberrant processing occurs following the expression of a mutant APP with Ala substituted for Asn, and that glycosylation may modulate the intracellular sorting of APP.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013347 Subcellular Fractions Components of a cell produced by various separation techniques which, though they disrupt the delicate anatomy of a cell, preserve the structure and physiology of its functioning constituents for biochemical and ultrastructural analysis. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p163) Fraction, Subcellular,Fractions, Subcellular,Subcellular Fraction
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D016296 Mutagenesis Process of generating a genetic MUTATION. It may occur spontaneously or be induced by MUTAGENS. Mutageneses
D016564 Amyloid beta-Protein Precursor A single-pass type I membrane protein. It is cleaved by AMYLOID PRECURSOR PROTEIN SECRETASES to produce peptides of varying amino acid lengths. A 39-42 amino acid peptide, AMYLOID BETA-PEPTIDES is a principal component of the extracellular amyloid in SENILE PLAQUES. Amyloid A4 Protein Precursor,Amyloid Protein Precursor,beta-Amyloid Protein Precursor,Amyloid beta Precursor Protein,Protease Nexin 2,Protease Nexin II,Amyloid beta Protein Precursor,Nexin 2, Protease,Nexin II, Protease,beta Amyloid Protein Precursor,beta-Protein Precursor, Amyloid

Related Publications

M Yazaki, and K Tagawa, and K Maruyama, and H Sorimachi, and T Tsuchiya, and S Ishiura, and K Suzuki
The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer's Disease.
August 2021, Molecular neurobiology,
M Yazaki, and K Tagawa, and K Maruyama, and H Sorimachi, and T Tsuchiya, and S Ishiura, and K Suzuki
N-linked glycosylation of beta-amyloid precursor protein.
December 1992, Biochemical and biophysical research communications,
M Yazaki, and K Tagawa, and K Maruyama, and H Sorimachi, and T Tsuchiya, and S Ishiura, and K Suzuki
Processing of the Alzheimer's disease beta A4 amyloid protein precursor (APP).
July 1991, Brain pathology (Zurich, Switzerland),
M Yazaki, and K Tagawa, and K Maruyama, and H Sorimachi, and T Tsuchiya, and S Ishiura, and K Suzuki
Amyloid precursor protein gene (APP) variation in late-onset Alzheimer's disease.
September 2011, Journal of molecular neuroscience : MN,
M Yazaki, and K Tagawa, and K Maruyama, and H Sorimachi, and T Tsuchiya, and S Ishiura, and K Suzuki
AChE and the amyloid precursor protein (APP) - Cross-talk in Alzheimer's disease.
November 2016, Chemico-biological interactions,
M Yazaki, and K Tagawa, and K Maruyama, and H Sorimachi, and T Tsuchiya, and S Ishiura, and K Suzuki
E674Q (Shanghai APP mutant), a novel amyloid precursor protein mutation, in familial late-onset Alzheimer's disease.
March 2024, Genes & diseases,
M Yazaki, and K Tagawa, and K Maruyama, and H Sorimachi, and T Tsuchiya, and S Ishiura, and K Suzuki
[Familial Alzheimer's disease by beta-amyloid protein precursor (beta APP) mutations].
January 2004, Nihon rinsho. Japanese journal of clinical medicine,
M Yazaki, and K Tagawa, and K Maruyama, and H Sorimachi, and T Tsuchiya, and S Ishiura, and K Suzuki
Screening of amyloid precursor protein gene mutation (APP 717 Val-->Ile) in Swedish families with Alzheimer's disease.
January 1993, Journal of neural transmission. Parkinson's disease and dementia section,
M Yazaki, and K Tagawa, and K Maruyama, and H Sorimachi, and T Tsuchiya, and S Ishiura, and K Suzuki
Amyloid precursor protein (APP) and beta A4 amyloid in Alzheimer's disease and Down syndrome.
January 1992, Progress in clinical and biological research,
M Yazaki, and K Tagawa, and K Maruyama, and H Sorimachi, and T Tsuchiya, and S Ishiura, and K Suzuki
Amyloid precursor protein (APP) in the striatum in Alzheimer's disease: an immunohistochemical study.
January 1993, Journal of neuropathology and experimental neurology,
Copied contents to your clipboard!